XENON PHARMACEUTICALS INC's ticker is XENE and the CUSIP is 98420N105. A total of 135 filers reported holding XENON PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 10.04 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $707 | -8.4% | 20,000 | 0.0% | 0.00% | 0.0% |
| Q2 2023 | $772 | +9.0% | 20,000 | 0.0% | 0.00% | 0.0% |
| Q1 2023 | $708 | -9.3% | 20,000 | 0.0% | 0.00% | 0.0% |
| Q4 2022 | $781 | -99.9% | 20,000 | 0.0% | 0.00% | 0.0% |
| Q3 2022 | $721,000 | +90.7% | 20,000 | +61.3% | 0.00% | +100.0% |
| Q2 2022 | $378,000 | +1.3% | 12,400 | 0.0% | 0.00% | 0.0% |
| Q1 2022 | $373,000 | +3.9% | 12,400 | +9.7% | 0.00% | 0.0% |
| Q4 2021 | $359,000 | +121.6% | 11,300 | +2.7% | 0.00% | – |
| Q3 2021 | $162,000 | -17.3% | 11,000 | 0.0% | 0.00% | -100.0% |
| Q2 2021 | $196,000 | +3.2% | 11,000 | 0.0% | 0.00% | 0.0% |
| Q1 2021 | $190,000 | +21.0% | 11,000 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $157,000 | – | 11,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ally Bridge Group (NY) LLC | 266,961 | $10,277,999 | 12.45% |
| COMMODORE CAPITAL LP | 1,845,000 | $71,032,500 | 7.98% |
| Altium Capital Management LP | 228,000 | $8,778,000 | 6.64% |
| TLS Advisors LLC | 33,756 | $1,300 | 5.58% |
| GREAT POINT PARTNERS LLC | 530,000 | $20,405,000 | 3.99% |
| DAFNA Capital Management LLC | 280,538 | $10,800,713 | 2.95% |
| Paradigm Biocapital Advisors LP | 989,327 | $38,089,090 | 2.94% |
| Nan Fung Group Holdings Ltd | 114,380 | $4,403,630 | 2.81% |
| Avoro Capital Advisors LLC | 4,900,000 | $188,650,000 | 2.56% |
| Ghost Tree Capital, LLC | 185,000 | $7,122,500 | 2.35% |